COVID-19

"Patient care doesn't stop with COVID-19"

Johnson & Johnson released a statement providing more information on the risks and benefits of its single-shot COVID-19 vaccine.

Patients with cancer with complete COVID-19 vaccinations demonstrated a high rate of antibodies, according to the study.

Pharmacists reflect on their takeaways from the experience and how to move forward.

Administering pediatric immunizations can be a window of opportunity for pharmacists to demonstrate their value.

In part 2 of our interview, Jason Ausili, PharmD, speaks to the challenges of COVID-19 vaccination processes and dives into technology solutions for these workflow barriers.

The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.

Many Americans still do not want to get vaccinated. Vaccine myths spread on the internet are a major part of the problem.

Novavax’s recombinant nanoparticle protein-based COVID-19 vaccine showed an overall efficacy of 90.4% and 100% efficacy against moderate and severe disease.

Moderna has filed for FDA emergency use authorization for use of its COVID-19 vaccine in adolescents aged 12 through 17.

Here’s a roundup of the latest coronavirus-related news.

Jason Ausili, PharmD, highlights President Biden's expectations for community pharmacies amid the COVID-19 vaccination effort.

The antibody combination COVID-19 treatment is the only one of its kind available in the United States.

Here’s a roundup of the latest coronavirus-related news.

Most pharmacists who participated in the survey also said they were comfortable addressing vaccine hesitancy with their patients.

Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.

Migraine sufferers reported worsened symptoms during social distancing, which may be attributed to reduced sleep quality and physical activity.

Here’s a roundup of the latest coronavirus-related news.

Sotrovimab is authorized to treat COVID-19 patients 12 years of age and older with mild-to-moderate infection and who are at high risk for severe disease progression.

Vaccination activities build on collective success of COVID-19 response over the past year

The company has publicized data from the TeenCOVE study of the vaccine along with plans to seek authorization in the coming weeks.

In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.

The Practice Advisory, developed by the American College of Obstetricians and Gynecologists (ACOG), offers an overview of the latest guidance for COVID-19 vaccination in pregnant and lactating patients.

Individuals with opioid misuse disorders may be experiencing decreased access to naloxone during the COVID-19 pandemic.

Here’s a roundup of the latest coronavirus-related news.

A research letter reported that robust secretion of SARS-CoV-2 specific IgA and IgG antibodies were found in breast milk of breastfeeding women for 6 weeks after the first of 2 vaccinations against COVID-19.

A session from the 2021 PQA Annual Meeting highlighted the benefits of virtual outreach in advancing patient care amid the COVID-19 pandemic and beyond.

There is currently limited data on COVID-19 vaccine safety and efficacy in pregnant and lactating women.

With all Americans over 12 years able to get vaccinated for COVID-19 and the CDC releasing recent changes to guidelines for fully vaccinated individuals, it’s more important than ever to stay up-to-date on COVID-19 headlines.

The CDC today announced an updated guidance on mask wearing and social distancing for individuals fully vaccinated against COVID-19.